logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
E

Expert Opinion on Drug Metabolism & Toxicology

IF3.4
Papers50
Citations
Journal Papers 50
Publication Date
delete
An update on beta-lactam–beta-lactamase inhibitor combinations for the treatment of carbapenem-resistant Gram-negative pathogens
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-06-30
delete0
deleteOAAI
deleteIlias Karaiskos; Aikaterini Gkoufa; Evdoxia Kyriazopoulou; Eleni Polyzou; Vasiliki Rapti; Konstantinos Ioannidis; Evangelia Chrysanthopoulou; Zoe Athanassa; Karolina Akinosoglou; Garyphalia Poulakou; null
deleteShare
deleteSave
The use of natural language processing in predictive toxicology
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-06-29
delete0
deleteOAAI
deleteThomas Hartung
deleteShare
deleteSave
Effect of concomitant rifampin and clarithromycin on elexacaftor-tezacaftor-ivacaftor using a physiologically based pharmacokinetic (PBPK) modeling approach
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-06-23
delete0
PREAI
deleteMadeline Sanders; Eunjin Hong; Manya Jain; Paul Beringer
deleteShare
deleteSave
Optimizing tamoxifen therapy in breast cancer: a narrative review of dose escalation in patients with CYP2D6 polymorphisms
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-06-22
delete0
PREAI
deleteJuliana Henrique Duarte; Jose Claudio Casali-da-Rocha; Rafael Linden; Marina Venzon Antunes
deleteShare
deleteSave
Sex differences and impact of age-based menopausal status on tacrolimus pharmacokinetics: results of the TransplantLines Biobank and Cohort study
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-06-15
delete0
deleteOAAI
deleteTanja R. Zijp; Svea Nolte; Tim J. Knobbe; Vincent E. de Meijer; C. Tji Gan; Stephan J.L. Bakker; Iris E. Sommer; Sieta T. de Vries; Daan J. Touw; null
deleteShare
deleteSave
Gastrointestinal bleeding risk among antithrombotics users: a propensity score matched study of drug classes
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-06-10
delete0
PREAI
deletePrajwal M. Pradhan; Erich Kummerfeld; Steven Johnson; Gyorgy Simon; Terrence Adam
deleteShare
deleteSave
Complex in vitro model developers’ perspective on advanced hepatic in vitro culture methods for predictive drug safety
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-06-03
delete0
deleteOAAI
deleteMaria Vittoria Colombo; Anna Borgström; Bruno Guy Henri Filippi
deleteShare
deleteSave
Evaluation of the pharmacokinetics of emerging therapeutics for high grade glioma
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-06-03
delete0
PREAI
deleteAntonio Ruggiero
deleteShare
deleteSave
Transplacental pharmacokinetics and developmental toxicity of chemotherapeutic agents: a comparative analysis of fetal and pediatric exposure profiles
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-06-02
delete0
PREAI
deleteAntonio Ruggiero
deleteShare
deleteSave
Citalopram serum concentrations in men and women of pre- and post-menopausal age
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-06-01
delete0
deleteOAAI
deleteEline L. Bosch; Franciska de Beer; Danielle C. Cath; Shiral S. Gangadin; Daan J. Touw; Iris E.C. Sommer
deleteShare
deleteSave
Clinical, toxicological and pharmacokinetic data of emerging drugs for the treatment of atherosclerosis: are they promising?
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-05-20
delete0
deleteOAAI
deleteKhaled Naja; Mohamed A. Elrayess; Manfredi Rizzo
deleteShare
deleteSave
Exploring the influence of sex on idiosyncratic DILI: impact on risk assessment
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-05-11
delete0
PREAI
deleteAyako Suzuki; Einar S. Björnsson
deleteShare
deleteSave
Esketamine for major depressive disorder: pharmacokinetics and toxicological considerations
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-05-01
delete0
PREAI
deleteVasudeva, Shreya; Lovell, Gabrielle F. M.; Rosenblat, Joshua D.
deleteShare
deleteSave
Rethinking pharmacokinetics in preterm and term neonates and infants: sex as a critical biological variable
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-05-01
delete0
PREAI
deleteCampesi, Ilaria; Montella, Andrea; Franconi, Flavia
deleteShare
deleteSave
New insights into the role of CYP26 in retinoic acid clearance
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-04-28
delete0
deleteOAAI
deleteJamie Innes; Andrew Whiting; Peter McCaffery
deleteShare
deleteSave
Pharmacogenomic and inflammatory determinants of antipsychotic-induced extrapyramidal toxicity in Egyptian patients with schizophrenia
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-04-19
delete0
PREAI
deleteAsmaa Mohamed Sayed Ahmed; Asmaa Mohammad Moawad; Mennat-Allah Tarek; Marwa Abdelgwad; Alaa Mohamed Ibrahim Aboutaleb; Abrar Roshdy Abouelkheir
deleteShare
deleteSave
Clinically significant interactions between drugs, microbiome, and sex
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-04-16
delete0
PREAI
deleteSlobodan M. Janković
deleteShare
deleteSave
Post-marketing pharmacovigilance of tedizolid: emerging safety signals
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-04-15
delete0
PREAI
deleteHaiping Yao; Guoping Gan; Zhu Wang
deleteShare
deleteSave
Impact of green tea on pharmacokinetics in cardiovascular therapy: current insights
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-04-07
delete0
deleteOAAI
deleteShingen Misaka; José Pablo Werba
deleteShare
deleteSave
Substrate-specificity of pharmacogenomic variability – clinical relevance and emerging predictive strategies
deleteExpert Opinion on Drug Metabolism & Toxicology
IF3.4
delete2026-04-02
delete0
deleteOAAI
deleteYitian Zhou; Yoomi Park; Volker M. Lauschke
deleteShare
deleteSave